XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenues $ 1,304,668 $ 1,005,754 $ 728,723
Operating expenses:      
Cost of revenues (excluding depreciation and amortization) 513,587 399,552 274,482
General and administrative expenses 233,024 204,595 205,419
Selling and marketing expenses 340,040 314,514 288,441
Research and development expenses 117,173 90,679 73,869
Depreciation and amortization 72,039 56,100 51,149
Acquisition-related expenses 20,281 8,229 203
Restructuring expenses 3,152 0 2,845
Total operating expenses 1,299,296 1,073,669 896,408
Income / (loss) from operations 5,372 (67,915) (167,685)
Interest expenses, net 371 7,147 10,939
Other expenses / (income) 38,088 (115) 7,820
Total other expenses 38,459 7,032 18,759
Loss before income taxes (33,087) (74,947) (186,444)
Income tax (benefit) / provision (1,578) (5,176) 1,037
Net loss (31,509) (69,771) (187,481)
Other comprehensive (income) / loss:      
Foreign currency translation adjustment (2,479) 3 (35)
Total comprehensive loss (29,030) (69,774) (187,446)
Net loss per share      
Net loss available to common stockholders $ (31,509) $ (69,771) $ (187,481)
Basic loss per share $ (0.14) $ (0.38) $ (1.2)
Diluted loss per share $ (0.14) $ (0.38) $ (1.2)
Weighted average number of shares used to compute net loss per share      
Basic 220,722,814 185,984,107 156,697,308
Diluted 220,722,814 185,984,107 156,697,308